This AI-generated summary is based on the following references:

1. Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025 May [DOI: 10.1016/j.jhep.2025.03.018]

‌

This AI-generated summary is based on the following references:

1. Gebara NY, El Kamari V, Rizk N. HIV-1 elite controllers: an immunovirological review and clinical perspectives. Journal of Virus Eradication. 2019 Jul;5(3):163–6.

‌2. Khan M, Bradshaw D, Brown CS, Haddow J, Patel P, Tosswill JHC, et al. Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. Open Forum Infectious Diseases. 2023 Mar 1;10(5).

‌3. Giliauskas D. Considerations for the clinical management of HIV elite controllers – The Ontario HIV Treatment Network. 2018.

‌

This AI-generated summary is based on the following references:

1. Sorina Șoldea, Iovănescu M, Mihaela Berceanu, Oana Mirea, Raicea V, Beznă MC, et al. Cardiovascular Disease in HIV Patients: A Comprehensive Review of Current Knowledge and Clinical Implications. International Journal of Molecular Sciences. 2025 Feb 21;26(5):1837–7.

2. Ghandakly E, Rohit Moudgil, Holman K. Cardiovascular disease in people living with HIV: Risk assessment and management. Cleveland Clinic Journal of Medicine. 2025 Mar 1;92(3):159–67.

3. Henning RJ, Greene JN. The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV. American Journal of Cardiovascular Disease. 2023 Apr 15;13(2):101.

‌

‌

‌